146.47
price down icon0.62%   -0.92
 
loading

Finanzdaten der Biogen Inc-Aktie (BIIB)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
4.01%
2,290.50
2,386.30 2,530.30 2,456.00 2,463.00
Cost Of Revenue
12.31%
542.20
618.30 659.60 592.70 662.80
Gross Profit
1.11%
1,748.30
1,768.00 1,870.70 1,863.30 1,800.20
Operating Expenses
13.07%
1,283.50
1,476.40 2,011.90 1,155.20 1,361.90
Interest Income/Expense
3.22%
69.20
71.50 63.80 49.10 62.50
Benefits Costs and Expenses
12.84%
1,825.70
2,094.70 2,671.50 1,747.90 2,024.70
Costs And Expenses
12.84%
1,825.70
2,094.70 2,671.50 1,747.90 2,024.70
Operating Income/Loss
59.40%
464.80
291.60 -141.20 708.10 438.30
Income/Loss From Continuing Operations Before Tax
59.40%
464.80
291.60 -141.20 708.10 438.30
Income Tax Expense/Benefit, Deferred
44.51%
39.90
71.90 -206.80 -106.40 -64.50
Income Tax Expense/Benefit
67.21%
71.40
42.70 -72.90 114.80 50.70
Income/Loss From Continuing Operations After Tax
58.06%
393.40
248.90 -68.30 593.30 387.60
Net Income/Loss
58.06%
393.40
248.90 -68.30 593.30 387.60
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
100.00%
-
-0.80 -0.20 1.70 -0.30
Basic Average Shares
145.20
- 144.80 144.70 144.40
Diluted Average Shares
145.80K%
145.90
0.10 144.80 145.50 145.20
Basic Earnings Per Share
57.56%
2.71
1.72 -0.47 4.09 2.69
Diluted Earnings Per Share
57.89%
2.70
1.71 -0.47 4.07 2.67
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
drug_manufacturers_general BMY
$57.33
price up icon 1.83%
drug_manufacturers_general SNY
$47.71
price up icon 0.44%
$263.38
price up icon 0.84%
drug_manufacturers_general PFE
$26.36
price up icon 2.29%
drug_manufacturers_general NVS
$97.11
price up icon 0.35%
drug_manufacturers_general MRK
$98.05
price down icon 1.48%
Kapitalisierung:     |  Volumen (24h):